Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Switzerland

High Generic Drug Market Growth Potential

May 2011 | Industry Trend Analysis

BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts on generic medicines and their increasing affordability will work towards increasing the consumption of generic medicines in Switzerland, BMI believes the government needs to do more to alter patients' attitudes towards such drugs - the main deterrent of growth.

To read the full article, please choose one of the following options:

Subcribers please log in

Western Europe InsightWestern Europe Channels Western Europe Countries